GLP-1 Providers in Connecticut (2026)

181 sellers list Connecticut as a shipping state. The lowest regular price among them is $64/mo, and Connecticut Medicaid does not cover weight loss.

181 sellersfrom $64/moMedicaid does not cover weight loss

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

181 of the 238 sellers that publish a state list include Connecticut, the 19th-most of the 50 states and DC. 128 of them ship to all 50 states, and 1 serves 15 states or fewer. Across the 150 with a regular monthly price, the middle figure is $175/mo.

Connecticut Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

Featured Partners · Connecticut

Featured GLP-1 providers serving Connecticut

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

  1. Top pick

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  4. Compounded from

    $179/mo

    Save $1,170/mo vs Wegovy
    Get started →
  5. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  6. Compounded from

    $112/mo

    Save $1,237/mo vs Wegovy
    Get started →

Who Ships GLP-1s to Connecticut

  1. RxPepsDirect $64/mo
  2. Embody $79/mo
  3. Lean Meds $79/mo

Lowest regular prices for Connecticut: RxPepsDirect at $64/mo, Embody at $79/mo and Lean Meds at $79/mo.

Smaller-footprint sellers that include Connecticut: PCOS Sisters (12 states).

3 sellers that list 30 or more states leave Connecticut off, among them Curex, Brello Health and Fierce Health.

Seller counts next door: Massachusetts 174, New York 193 and Rhode Island 169.

Browse by medication

Connecticut Medicaid and GLP-1 Coverage

Connecticut Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

  • Wegovy to cut heart attack and stroke risk: covered with prior authorization (age of at least 18; established cardiovascular disease (symptomatic peripheral artery disease, or a prior stroke whether ischemic or hemorrhagic, or a prior heart attack); obesity or overweight; no NYHA Class IV Heart Failure).
  • Wegovy for the liver disease MASH: covered with prior authorization.
  • Zepbound for obstructive sleep apnea: covered with prior authorization (an AHI of at least 15; a CPAP trial first).
Prior authorization
Prior authorization formWegovy MACE / Wegovy MASH / Zepbound OSA PA forms at ctdssmap.com; fax to Gainwell Technologies
Prior authorization phone1-866-409-8386
Prior authorization fax1-866-759-4110
Pharmacy benefit managerGainwell Technologies (claims + PA) + Prime Therapeutics (TOP$/PDL) + Acentra Health (RetroDUR)
Enrollmentabout 930,000 people (2026)
If the request is denied
Time to file an appeal60 days
Appeals officeDSS Office of Legal Counsel, Regulations and Administrative Hearings (OLCRAH)
Fast-track appealavailable when waiting would put your health at risk
“Wegovy will NOT be covered: Exclusively for weight management, or Type 1 or Type 2 diabetes, or For those who are also diagnosed with New York Heart Association Class IV Heart Failure.”
Connecticut DSS Provider Bulletin 2025-04 (Wegovy MACE PA, effective Feb 3, 2025)

In 2025, Connecticut Medicaid paid for at least 174,430 GLP-1 prescriptions, including at least 101,853 for Ozempic, at least 2,125 for Wegovy, 50,327 for Mounjaro and at least 3,350 for Zepbound, about $202.7 million before manufacturer rebates. Drugs labeled for weight loss made up 3% of that spending.

Medicaid rules checked May 2026. Prescription counts: CMS State Drug Utilization Data. Check your eligibility

Specialist Clinics and Obesity in Connecticut

Connecticut has 442 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 12.03 per 100,000 residents (4th of 51). By specialty: 172 bariatric, 272 endocrinology and 5 obesity medicine. About 32% of adults here had obesity in 2024 (CDC), the 36th-highest rate of the 50 states and DC. Measured against the median state, Connecticut has 0.66 times as much adult obesity per specialist practice.

Every GLP-1 Provider Serving Connecticut

9.3/ 10
Verified partner

Embody

Best for: knowing which pharmacy fills the vial: it names RedRock Pharmacy

★★★★★4.7/5

Editorial score · methodology

$79/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Embody review →
9.0/ 10
Verified partner

Live Vital

Best for: semaglutide at $99/month, 48% below the typical price

★★★★★4.5/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideRetatrutideBPC-157
Get StartedRead full Live Vital review →
8.7/ 10
Verified partner

Gala

Best for: moving between compounded and brand without changing seller

★★★★☆4.4/5

Editorial score · methodology

$129/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full Gala review →
8.6/ 10
Verified partner

Found

Best for: tirzepatide at $169/month, 37% below the typical price

★★★★☆4.3/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Found review →
7.3/ 10
Verified partner

Willow

Best for: seeing what it charges before you answer any medical questions

★★★★☆3.7/5

Editorial score · methodology

$299/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Willow review →
Open the full A–Z list of 181 providers in Connecticut

312 more sellers publish no state list

Their signup form tells you whether they ship to Connecticut.

5.7/ 10
Verified partner

HumeCare+

Best for: an oral route if you will not self-inject

★★★☆☆2.9/5

Editorial score · methodology

$199/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full HumeCare+ review →
6.5/ 10
Verified partner

Sesame Care

Best for: oral orforglipron alongside the injectables

★★★☆☆3.3/5

Editorial score · methodology

$59/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
8.4/ 10
Verified partner

Collective

Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top

★★★★☆4.2/5

Editorial score · methodology

$59/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
7.7/ 10
Verified partner

HealthRX

Best for: compounded semaglutide at $133/month

★★★★☆3.9/5

Editorial score · methodology

$133/mo
SemaglutideTirzepatide
Get StartedRead full HealthRX review →
7.3/ 10
Verified partner

RNK Health

Best for: an oral route if you will not self-inject

★★★★☆3.7/5

Editorial score · methodology

$197/mo
CompoundedSemaglutideTirzepatideNAD+Sermorelin
Get StartedRead full RNK Health review →
5.9/ 10
Verified partner

SkinnyRx

Best for: starting below a standard dose, with microdose tiers

★★★☆☆3/5

Editorial score · methodology

$149.25/mo
CompoundedSemaglutideTirzepatideFDA Warning
Get StartedRead full SkinnyRx review →

Largest Cities in Connecticut

BridgeportNew HavenStamfordHartford

Frequently Asked Questions

The lowest regular prices from sellers that ship to Connecticut are $64/mo at RxPepsDirect, $79/mo at Embody and $79/mo at Lean Meds. Half of the 150 priced sellers charge $175/mo or less.
Connecticut Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization. Wegovy to cut heart attack and stroke risk: covered with prior authorization (age of at least 18; established cardiovascular disease (symptomatic peripheral artery disease, or a prior stroke whether ischemic or hemorrhagic, or a prior heart attack); obesity or overweight; no NYHA Class IV Heart Failure). Wegovy for the liver disease MASH: covered with prior authorization. Zepbound for obstructive sleep apnea: covered with prior authorization (an AHI of at least 15; a CPAP trial first).
Your prescriber sends the request on this paperwork: Wegovy MACE / Wegovy MASH / Zepbound OSA PA forms at ctdssmap.com; fax to Gainwell Technologies. Pharmacy claims run through Gainwell Technologies (claims + PA) + Prime Therapeutics (TOP$/PDL) + Acentra Health (RetroDUR). The prior authorization phone line is 1-866-409-8386.
A denial can be appealed within 60 days through the DSS Office of Legal Counsel, Regulations and Administrative Hearings (OLCRAH). A fast-track appeal is available when waiting would put your health at risk.
181, counting sellers whose published state list includes Connecticut. 128 of those list every state, and PCOS Sisters is among the few that serve 15 states or fewer. For comparison, Massachusetts has 174, New York has 193 and Rhode Island has 169.
Curex (45 states), Brello Health (35 states) and Fierce Health (30 states) publish long state lists that leave Connecticut out.
In 2025, Connecticut Medicaid paid for at least 174,430 GLP-1 prescriptions, including at least 101,853 for Ozempic, at least 2,125 for Wegovy, 50,327 for Mounjaro and at least 3,350 for Zepbound, about $202.7 million before manufacturer rebates. Drugs labeled for weight loss made up 3% of that spending.
Connecticut has 442 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 12.03 per 100,000 residents (4th of 51). By specialty: 172 bariatric, 272 endocrinology and 5 obesity medicine. About 32% of adults here had obesity in 2024 (CDC), the 36th-highest rate of the 50 states and DC. Measured against the median state, Connecticut has 0.66 times as much adult obesity per specialist practice.

Rankings: semaglutide providers · tirzepatide providers · clinical-trial results · GLP-1 pipeline

Glossary

The words sellers use, defined. Tap any term.